Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
41.1M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
22.6M
-
Shares change
-
-26.3K
-
Total reported value, excl. options
-
$32.5M
-
Value change
-
-$34.5K
-
Number of buys
-
8
-
Number of sells
-
-5
-
Price
-
$1.44
Significant Holders of Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) as of Q2 2025
20 filings reported holding ANEB - Anebulo Pharmaceuticals, Inc. - Common Stock as of Q2 2025.
Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.6M shares
of 41.1M outstanding shares and own 55.02% of the company stock.
Largest 10 shareholders include 22NW, LP (15.5M shares), Nantahala Capital Management, LLC (3.04M shares), MANGROVE PARTNERS IM, LLC (2.53M shares), MORGAN STANLEY (399K shares), LVW Advisors, LLC (350K shares), VANGUARD GROUP INC (216K shares), GEODE CAPITAL MANAGEMENT, LLC (206K shares), Ikarian Capital, LLC (158K shares), MILLENNIUM MANAGEMENT LLC (154K shares), and CITADEL ADVISORS LLC (25K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.